Multi-drug-resistant tuberculosis: Difference between revisions
| Line 18: | Line 18: | ||
==[[Multi-drug-resistant tuberculosis epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Multi-drug-resistant tuberculosis epidemiology and demographics|Epidemiology and Demographics]]== | ||
[[File:Notified MDR-TB cases (absolute numbers), 2012.png|thumb|center|600 px|''Image 1''-Notified MDR-TB cases (absolute numbers), 2012.png<SMALL><SMALL>''[https://extranet.who.int/sree/Reports?op=vs&path=/WHO_HQ_Reports/G2/PROD/EXT/MDRTB_Indicators_map)]''<ref name="WHO">{{Cite web | title = World health organization (WHO) | url = https://extranet.who.int/sree/Reports?op=vs&path=/WHO_HQ_Reports/G2/PROD/EXT/MDRTB_Indicators_map}}</ref></SMALL></SMALL>]] | |||
==[[Multi-drug-resistant tuberculosis risk factors|Risk Factors]]== | ==[[Multi-drug-resistant tuberculosis risk factors|Risk Factors]]== | ||
Revision as of 20:28, 29 September 2014
For patient information, click here
|
Multi-drug-resistant tuberculosis Microchapters |
|
Differentiating Multi-drug-resistant tuberculosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Multi-drug-resistant tuberculosis On the Web |
|
American Roentgen Ray Society Images of Multi-drug-resistant tuberculosis |
|
Directions to Hospitals Treating Multi-drug-resistant tuberculosis |
|
Risk calculators and risk factors for Multi-drug-resistant tuberculosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Alejandro Lemor, M.D. [3]; Ammu Susheela, M.D. [4]
Synonyms and keywords: Multi-drug resistant tuberculosis, MDR-TB
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multi-drug-resistant tuberculosis from other Diseases
Epidemiology and Demographics
,_2012.png)
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies